Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 203–203 | Cite as

Oxaliplatin

Peripheral neuropathy: case report
Case report
  • 20 Downloads

Reference

  1. Cazelles C, et al. Rituximab, gemcitabine and oxaliplatin (R-gemox) in refractory/relapsed patients not candidates for high-dose therapy with diffuse large b-cell lymphoma (DLBCL). a single center study of 115 patients. HemaSphere 2 (Suppl. 2): 91, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] - France

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations